Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Research and Innovation Action · Running

EuCARE European Cohorts of Patients and Schools to Advance Response to Epidemics

Coordinator
Euresist Network Geie, Italy
Runs
14 October 2021 to 13 October 2026
Status
Running
EU funding
€10.0m
Total cost
€10.0m
Partners
20 organisations in 10 countries
Type
Research and Innovation Action
Grant agreement
101046016

What the project is doing

In the project's own words, from its summary on CORDIS.

The EuCARE project gathers a comprehensive multidisciplinary team of clinicians, virologists, epidemiologists, statisticians and top experts in artificial intelligence to unveil the impact of SARS-CoV-2 variants on key sectors of public health, as addressed by the call. The specific activities include:1.The assessment of natural and artificial immunity to the different viral variants in health care workers with the aim of defining the cross-immunization patterns and the risk of vaccine escape, informing vaccination strategies for the general population; 2.The analysis of the clinical course and long-term follow-up of hospitalized COVID-19 patients to derive the role of different viral variants in the outcome of the infection, including post-acute sequelae of SARS-CoV-2 infection; 3.The definition of the best strategies to control the spread of different viral variants in schools, by comparing the outcome of diverse containment and prevention measures in relation to the prevalence and dynamics of the variants.

To ensure a suitable representativeness of the different variants, vaccines and preventive measures, EuCARE has secured the appropriate cohorts from diverse geographic areas including European countries, Kenya, Mexico, Russia and Vietnam, and will consolidate or expand interactions with other cohorts. To deal with complex interactions among many variables, including large dimensional parameters, EuCARE harnesses the power of artificial intelligence to define the role of viral variants and inform clinical guidelines and prevention measures.

In the longer-term, EuCARE is committed to maintain active cooperation beyond the duration of the project with a dedicated task in the project. The solid IT and ethics infrastructure and the harmonised research procedures will make the cohort and laboratory network rapidly available to tackle newly emerging infectious diseases, thus contributing to pandemic preparedness on a global scale.

Topics

Who is involved

OrganisationCityCountryRole
Euresist Network GeieRoma RmItalyCoordinator
Organizing Bureau of European School Student UnionsBruxelles / BrusselBelgiumParticipant
Eberhard Karls Universitaet TuebingenTuebingenGermanyParticipant
Heinrich-Heine-Universitaet DuesseldorfDusseldorfGermanyParticipant
Klinikum Der Universitaet Zu KoelnKoelnGermanyParticipant
Infectious Diseases, Aids and Clinical Immunology Research CenterTiblisiGeorgiaParticipant
Ibm Israel - Science and Technology LtdPetach TikvaIsraelParticipant
Azienda Socio-Sanitaria Territoriale (asst) Santi Paolo E CarloMilanoItalyParticipant
Istituto Europeo Di Oncologia SRLMilanoItalyParticipant
Istituto Nazionale per Le Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura a Carattere ScientificoRomaItalyParticipant
Universita Degli Studi Di Roma Tor VergataRomaItalyParticipant
Universita Degli Studi Di SienaSienaItalyParticipant
Universita Del SalentoLecceItalyParticipant
Vilniaus Universiteto Ligonine Santaros KlinikosVilniusLithuaniaParticipant
Pomorski Uniwersytet Medyczny W SzczecinieSzczecinPolandParticipant
Unidade Local De Saude Lisboa Ocidental EpeLisboaPortugalParticipant
Universidade Nova De LisboaLisboaPortugalParticipant
Karolinska InstitutetStockholmSwedenParticipant
Imperial College of Science Technology and MedicineLondonUnited KingdomParticipant
University College LondonLondonUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI